BC Centre on Substance Use Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2019
NCT03948464
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

BC Centre on Substance Use | M. Eugenia Socias

Active Ingredients

Drugs in Phase 4 Trials (1)

buprenorphine (1 trial)

Drugs in Phase 3 Trials (2)

methadone (methadose) (1 trial)

morphine (1 trial)

Drugs in Phase 2 Trials (1)

cannabinoids (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 3)

Opioid-Related Disorders (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4